Advertisement

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Opening Session Panel Discussion

Varsha Gandhi, PhD, on Ibrutinib

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Deborah Collyar: What's In It for Patients?

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement

Sep

09

Today In Oncology

NSCLC FDA Grants Accelerated Approval to Sevabertinib for Locally Advanced or Metastatic Nonsquamous Disease

Refined Risk Index Improves Outcome Prediction After Limited-Duration CLL Therapy

SUO/AUA Updates Guidelines for Non-Muscle Invasive Bladder Cancer

Pirtobrutinib Triplet Improves Progression-Free Survival in Previously Treated CLL

Early ctDNA Molecular Response May Predict Outcomes With Azenosertib in Ovarian Cancer

Advertisement

© 2026 HSP News Service, L.L.C.